
Daily Derm Times: August 1, 2025
Key Takeaways
- August 2025 will host numerous dermatology conferences, offering insights into the latest field advancements.
- Sculptra and Restylane effectively restore skin volume and quality in patients on GLP-1 medications, according to a Galderma trial.
Catch up on dermatology news, highlights, and insights from the past 24 hours.
To stay up-to-date with the latest dermatology news, sign up to receive our
Dermatology Conferences and Meetings Calendar: August 2025
Dermatology Times has compiled a list of dermatological meetings taking place during the month of August.
Sculptra and Restylane Deliver 9-Month Skin, Confidence Boost Post-Medication Weight Loss
Michael Somenek, MD, shares how a first-of-its-kind Galderma trial using Sculptra and Restylane helped restore volume and skin quality in patients on GLP-1 medications.
Patterns of Cutaneous Reactions to Nemolizumab in AD
The study found no association between cutaneous events and baseline EASI scores, eosinophil counts, or IgE levels.
SPOOGE by Whitney Hovenic, MD, Aims to Bridge the Sunscreen Adherence Gap in a Unique Way
Whitney Hovenic, MD's new SPOOGE sunscreen hopes to engage Gen Z in sun protection, merging skincare with fun and effective sun care strategies.
Common Sunscreen Allergens: What to Watch For
Kolansky identifies oxybenzone and fragrances as leading causes of sunscreen allergies.
The Latest Trends in Laser and Energy-Based Dermatology
Dendy Engelman, MD, FACMS, FAAD, explores the latest advancements in laser and energy-based dermatological treatments, including skin resurfacing and body contouring.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















